Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	date of answer exactly: or between: and answering member constituency
creator	label
publisher	pref label
tabling member	label

Search

947011

	human indexable
	published
	registered interest
	answer date	04/09/2018
	date	23/07/2018
	date tabled	23/07/2018
	ddp created	23/07/2018 22:00:40
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/07/2018 22:19:17 04/09/2018 16:32:02
	hansard heading	NHS: Drugs
	house id	1
	identifier	167294
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	04/09/2018 16:00:47
	question text	To ask the Secretary of State for Health and Social Care, whether he has undertaken an impact assessment on the potential beneficial effects of regulating the dispensing of special medicinal products in England.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 167294
	type	WrittenParliamentaryQuestion
	uin	167294
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 04/09/2018 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1052329

	human indexable
	published
	registered interest
	answer date	05/02/2019
	date	31/01/2019
	date tabled	31/01/2019
	ddp created	31/01/2019 18:17:40
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	31/01/2019 18:26:53 05/02/2019 16:02:06
	hansard heading	Pneumococcal Diseases: Vaccination
	house id	1
	identifier	215204
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	05/02/2019 15:30:32
	question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to implement the recommendations of the Joint Committee on Vaccination and Immunisation (JCVI) on reducing the dosage of pneumococcal vaccine from three to two.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 215204
	type	WrittenParliamentaryQuestion
	uin	215204
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 05/02/2019 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1047025

	human indexable
	published
	registered interest
	answer date	28/01/2019
	date	23/01/2019
	date tabled	23/01/2019
	ddp created	23/01/2019 19:04:39
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/01/2019 19:15:02 28/01/2019 17:52:01
	hansard heading	NHS: Drugs
	house id	1
	identifier	211794
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	28/01/2019 17:20:24
	question text	To ask the Secretary of State for Health and Social Care, how many times he has used his powers under the Health Service Medical Supplies (Costs) Act 2017 to impose lower prices on unbranded generic or off-patent medicines sold to the NHS; and how many companies have had lowered prices as a result of those powers.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 211794
	type	WrittenParliamentaryQuestion
	uin	211794
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 28/01/2019 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1047029

	human indexable
	published
	registered interest
	answer date	28/01/2019
	date	23/01/2019
	date tabled	23/01/2019
	ddp created	23/01/2019 19:04:48
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/01/2019 19:15:11 28/01/2019 17:53:06
	hansard heading	Drugs: Price Caps
	house id	1
	identifier	211796
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	28/01/2019 17:21:43
	question text	To ask the Secretary of State for Health and Social Care, how many times his Department imposed financial penalties on pharmaceutical companies for failure to comply with regulations under the Medical Supplies (Costs) Act 2017 for (a) exceeding a price cap and (b) failure to record or provide requested information under a statutory scheme.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 211796
	type	WrittenParliamentaryQuestion
	uin	211796
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 28/01/2019 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1110241

	human indexable
	published
	registered interest
	answer date	11/04/2019
	date	08/04/2019
	date tabled	08/04/2019
	ddp created	08/04/2019 23:25:20
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/04/2019 23:55:37 11/04/2019 17:32:10
	hansard heading	NHS: Drugs
	house id	1
	identifier	242154
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/04/2019 16:57:37
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Scottish Government’s Chief Pharmaceutical Officer on the implementation of legislative changes in the Human Medicines (Amendment) Regulations 2019 (S.I., 2019, No. 62).
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 242154
	type	WrittenParliamentaryQuestion
	uin	242154
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 11/04/2019 answering member constituency South Ribble
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1082133

	human indexable
	published
	registered interest
	answer date	11/03/2019
	date	05/03/2019
	date tabled	05/03/2019
	ddp created	05/03/2019 21:10:43
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	06/03/2019 15:55:07 11/03/2019 19:04:03
	hansard heading	Antimicrobials: Prices
	house id	1
	identifier	228682
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/03/2019 18:32:38
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Tackling Antimicrobial Resistance Action Plan 2019-2024, how delinking the price paid for antimicrobials from the volume sold will ensure that products produced by industry are affordable to the NHS.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 228682
	type	WrittenParliamentaryQuestion
	uin	228682
	version	2
	written parliamentary question type	NamedDay
	answer	answer date of answer 11/03/2019 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1082134

	human indexable
	published
	registered interest
	answer date	11/03/2019
	date	05/03/2019
	date tabled	05/03/2019
	ddp created	05/03/2019 21:10:46
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	05/03/2019 21:25:27 11/03/2019 19:04:01
	hansard heading	Antimicrobials: Prices
	house id	1
	identifier	228683
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/03/2019 18:32:38
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of using models that de-link the cost of research and development from the price of the final product and the volume of sales, as set out in the 2016 UN Political Declaration of the High-Level Meeting of the General Assembly on antimicrobial resistance, to ensure that new diagnostics, medicines and tools created are accessible and affordable.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 228683
	type	WrittenParliamentaryQuestion
	uin	228683
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 11/03/2019 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1130525

	human indexable
	published
	registered interest
	answer date	11/06/2019
	date	06/06/2019
	date tabled	06/06/2019
	ddp created	06/06/2019 17:02:14
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	06/06/2019 17:13:12 11/06/2019 16:18:03
	hansard heading	Doctors: Pensions
	house id	1
	identifier	261238
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/06/2019 15:46:09
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has conducted of the effect of the tapered annual pension tax allowance on the retention of doctors in the NHS.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 261238
	type	WrittenParliamentaryQuestion
	uin	261238
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 11/06/2019 answering member constituency Wimbledon
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1047027

	human indexable
	published
	registered interest
	answer date	28/01/2019
	date	23/01/2019
	date tabled	23/01/2019
	ddp created	23/01/2019 19:04:43
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/01/2019 19:15:06 28/01/2019 17:53:08
	hansard heading	NHS: Drugs
	house id	1
	identifier	211795
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	28/01/2019 17:21:03
	question text	To ask the Secretary of State for Health and Social Care, whether the NHS' spend on unbranded generic or off-patent medicines has reduced since the Health Service Medical Supplies (Costs) Act 2017 came into force.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 211795
	type	WrittenParliamentaryQuestion
	uin	211795
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 28/01/2019 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1110245

	human indexable
	published
	registered interest
	answer date	11/04/2019
	date	08/04/2019
	date tabled	08/04/2019
	ddp created	08/04/2019 23:25:49
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/04/2019 23:55:49 11/04/2019 16:45:13
	hansard heading	NHS: Drugs
	house id	1
	identifier	242155
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/04/2019 16:09:07
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with Scotland’s Cabinet Secretary for Health and Sport on the stockpiling of drugs in preparation for the UK’s departure from the EU.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 242155
	type	WrittenParliamentaryQuestion
	uin	242155
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 11/04/2019 answering member constituency Wimbledon
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford